FLUORIERTE ARYLALKYLAMINOCARBOXAMIDDERIVATE

European patent · EP2723710 · In force

Register entry

Publication number
EP2723710
Application number
EP12726067
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 29, 2012
Published
Apr 30, 2014
Granted
Aug 10, 2016
Protection ends at the latest
May 28, 2032
Next annual fee due
May 31, 2027
IPC classes
C07C 237/06 (2006.01)
C07D 209/08 (2006.01)
C07D 217/06 (2006.01)
C07D 265/36 (2006.01)
C07D 295/185 (2006.01)
C07D 295/182 (2006.01)
A61K 31/165 (2006.01)
A61P 25/00 (2006.01)
Priority
EP 11171522 27.06.2011
PCT application
PCT/EP2012/060006 29.05.2012
PCT publication
WO2013/000651 03.01.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 1, 2026

    Change

    Published in Swissreg on 01.06.2026

  2. Jun 1, 2025

    Change

    Published in Swissreg on 01.06.2025

  3. Jun 2, 2024

    Change

    Published in Swissreg on 02.06.2024

  4. Jun 9, 2023

    Change

    Published in Swissreg on 09.06.2023

  5. Sep 7, 2016

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 07.09.2016

  6. Aug 10, 2016

    Granted

    Published in Swissreg on 10.08.2016

Parties

Holder

Newron Pharmaceuticals S.p.A.

Via L. Ariosto, 21, 20091 Bresso (MI), IT

Agent

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventor

PEVARELLO, Paolo

27100 Pavia (PV), IT

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.